Navigation Links
Campbell Alliance Managed Markets Practice to Take a Leadership Role at the CBI Forum on Effective Product Pricing and Modeling Strategies

RALEIGH, N.C., April 3, 2008 /PRNewswire/ -- Campbell Alliance, the leading management consulting firm specializing in the pharmaceutical and biotech industries, today announced that its Managed Markets Practice will take a leadership role at the Premier Bio/Pharmaceutical Forum on Effective Product Pricing and Modeling Strategies hosted by the Center for Business Intelligence (CBI). The conference will be held on April 10 through 11 at the Doubletree Hotel in Philadelphia, Pennsylvania.

Members of the Managed Markets Practice will have three separate responsibilities at the event. On the first day of the conference, April 10, Steve Carter, a Vice President in the Managed Markets Practice at Campbell Alliance will present a session titled "Identify and Overcome the Most Common Pitfalls in Pharmaceutical Pricing." Mr. Carter's session will cover

* Common mistakes made by pricing professionals, with real-world examples

to illustrate them

* Limitations in the way many companies approach pricing

* Insights into how decision makers can overcome these limitations

Also on April 10, Mr. Carter will join colleagues Keith Kelly and Lujing Wang, two Practice Executives from the Managed Markets Practice, to facilitate an in-conference workshop titled "Develop a Pricing and Reimbursement Strategy in an Evolving Payer Environment." During the three-hour interactive workshop, participants will discuss the evolving reimbursement environment, learn how to develop and execute strong payer strategies, and collaborate with other workshop participants to develop an actual payer value proposition and a contracting and pricing strategy.

Lastly, on April 11, Steve Carter will join three other industry leaders in a panel discussion titled "Analyze Various Schools of Thought Regarding Pharmaceutical Pricing Methodologies" at 1:45 pm. The panelists will discuss the different schools of thought in pricing methodology and the advantages and disadvantages of each.

Steve Carter has provided consulting services to top pharmaceutical clients for more than a decade. His areas of expertise include pricing and contracting strategy, competitive assessment, research design, and analytical modeling. He holds a BS in economics from the Massachusetts Institute of Technology.

Keith Kelly provides management consulting services to pharmaceutical industry clients worldwide to increase their revenue and profits. Mr. Kelly has helped some of the leading pharmaceutical and biotech companies in the areas of pricing and contracting strategy, competitive assessment, research design, and analytical modeling. Mr. Kelly holds a BBA from Emory University's Goizueta Business School, where he majored in management and marketing.

Lujing Wang has helped many leading pharmaceutical and biotech companies successfully develop pricing, reimbursement, market access and medical affairs strategies in both the US and EU markets. His areas of expertise include health economics and outcomes research; financial, economic, and decision analytic modeling; as well as quantitative pricing research. Dr. Wang earned his Master of Public Health, Health Care Management from Harvard University School of Public Health. He also earned a Doctor of Medicine from Peking Union Medical College, and his undergraduate degree in pre-med was completed at Peking University School of Life Science.

For more information on CBI's Premier Bio/Pharmaceutical Forum on Effective Product Pricing and Modeling Strategies, please visit

About the Managed Markets Practice at Campbell Alliance

The Managed Markets Practice at Campbell Alliance helps clients stay informed about changing conditions affecting the reimbursement and access landscape, understand the implications of these trends, and deal more effectively with third-party payers. Services include
* Market assessments utilizing quantitative and qualitative research and

analysis, as well as decision-support modeling, and scenario planning

* Strategy development for key managed markets channels, such as the

creation of value propositions and pricing and contracting strategies

* Tactical execution, including account segmentation and prioritization

About Campbell Alliance

Campbell Alliance is the leading management consulting firm specializing in the pharmaceutical and biotechnology industry. The firm's clients include most of the world's top-20 pharmaceutical companies, as well as numerous emerging and midsize firms. Campbell Alliance is organized into practice areas, each specializing in a critical industry function, including Brand Management, Business Development, Clinical Development, Managed Markets, Sales, and Trade and Distribution. From its locations in Raleigh, NC, Parsippany, NJ, Los Angeles, San Francisco, Chicago, Boston, Philadelphia, New York City, and Atlanta, the firm serves clients throughout North America, Europe, and Japan. For more information on Campbell Alliance, please visit


James Forte

Director, Public and Media Relations

Campbell Alliance

919-844-7100, extension 7195

SOURCE Campbell Alliance
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Campbell Alliance Sales Practice to Conduct Workshop at EyeForPharma SFE Europe Conference
2. Campbell Alliance Brand Management and Managed Markets Practices to Speak at CBIs Early Commercialization Conference
3. Campbell Alliance Brand Management Practice to Discuss Managing Launch Logistics at the EyeForPharma Oncology Summit
4. Campbell Alliance Trade and Distribution Practice to Chair CBI 3rd Annual Fee for Service and EDI Data Management Conference
5. Campbell Alliance Launches New Practice Area Focused on Trade and Distribution
6. Campbell Alliance Business Development Practice to Moderate Two Workshops at LES Annual Meeting in Vancouver
7. Campbell Alliance Named Best Place to Work by Triangle Business Journal
8. Campbell Alliance Managed Markets Practice to Take Leadership Role at CBIs Formulary and Reimbursement Conference
9. Campbell Alliance to Moderate Senior-Level Panel Discussion at Windhover Pharmaceutical Strategic Alliances Conference
10. IC Sciences Launches ICS Alliance to Advance Development and Adoption of Informatics Instruments for Next Generation Healthcare
11. Merck & Co., Inc. Named Keynote Sponsor For Diversity Alliance For Sciences Inaugural Conference
Post Your Comments:
(Date:11/24/2015)... IN (PRWEB) , ... November 24, 2015 , ... The ... newest Special Interest Group (SIG), MultiGP, also known as Multirotor Grand Prix, to represent ... the last few years. Many AMA members have embraced this type of racing and ...
(Date:11/24/2015)... 24, 2015 --> ... report released by Transparency Market Research, the global non-invasive ... CAGR of 17.5% during the period between 2014 and ... Global Industry Analysis, Size, Volume, Share, Growth, Trends and ... testing market to reach a valuation of US$2.38 bn ...
(Date:11/24/2015)... 24, 2015 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: ... the remaining 11,000 post-share consolidation (or 1,100,000 pre-share ... "Series B Warrants") subject to the previously disclosed ... 23, 2015, which will result in the issuance ... to the issuance of such shares, there will ...
(Date:11/24/2015)... ... November 24, 2015 , ... In harsh industrial processes, ... for in-line sensors can represent a weak spot where leaking process media is ... retractable sensor housings , which are designed to tolerate extreme process conditions. They ...
Breaking Biology Technology:
(Date:11/2/2015)... Calif. , Nov. 2, 2015  SRI International ... million to provide preclinical development services to the National ... contract, SRI will provide scientific expertise, modern testing and ... variety of preclinical pharmacology and toxicology studies to evaluate ... --> The PREVENT Cancer Drug Development Program ...
(Date:10/29/2015)... Oct. 29, 2015  The J. Craig Venter Institute ... "DNA Synthesis and Biosecurity: Lessons Learned and Options for ... Health and Human Services guidance for synthetic biology providers ... --> --> Synthetic ... the potential to pose unique biosecurity threats. It now ...
(Date:10/29/2015)... ARBOR, Mich. , Oct. 29, 2015 /PRNewswire/ ... Eurofins Genomics for U.S. distribution of its DNA ... DNA-seq kit and Rubicon,s new ThruPLEX Plasma-seq kit. ... to enable the preparation of NGS libraries for ... plasma for diagnostic and prognostic applications in cancer ...
Breaking Biology News(10 mins):